ArticleMetabolomics : Official journal of the Metabolomic Society2026
NMR metabolomic profiling of cerebrospinal fluid from dogs with meningoencephalitis of unknown origin demonstrates metabolic similarities to multiple sclerosis.
Article in Metabolomics : Official journal of the Metabolomic Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMeningoencephalitis of unknown origin (MUO) in dogs is a debilitating and often fatal disease that shows similarities to multiple sclerosis (MS) in humans. The metabolomic profile of MUO has not been previously reported.
objectivesTo compare the metabolomic profile of cerebrospinal fluid (CSF) of dogs with MUO with two other diseases affecting the central nervous system in dogs, steroid responsive meningitis-arteritis (SRMA) and idiopathic epilepsy (IE), and to determine if the metabolic profile of MUO shows similarities with that of MS.
methodsUntargeted and semi-targeted metabolomics using
resultsFifty-six metabolites were identified in 56 dogs. The multivariate analysis of the canine data highlighted significant differences between the different disease groups. Most metabolites were increased in SRMA and decreased in IE when compared to MUO. Most affected metabolites included those involved in energy metabolism. Pathway analysis revealed that these metabolites were mainly involved in pyruvate metabolism, glycolysis or gluconeogenesis, glycine, serine and threonine metabolism and alanine, aspartate and glutamate metabolism.
conclusionThese results suggest that there is an increased energy demand in MUO. Our findings provide a first-time overview of CSF metabolic changes in MUO and offer potential insights for possible underlying pathogenesis and treatment strategies. Altered energy metabolism pathways are also reported in MS, further supporting the use of MUO as a spontaneous animal model for this disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.